The objective of the Administrative Core is to provide overall guidance, coordination and leadership for the Center. The administrative and scientific leadership of the Center is provided by Dr. N.F. LaRusso, Director, and Drs. G. Farrugia, G.J Gores, and V.H. Shah, Associate Directors, in conjunction with an Executive Committee, an Internal Advisory Committee-, and an External Advisory Committee. The Executive Committee is comprised of the Director, Associate Directors, Core Directors, and the Leaders of the Mechanistic Research Theme groups (Signal Transduction, Membrane Receptors/Ion Channels, and Genetics/Gene Regulation) and meets monthly. The Executive Committee will periodically assess the Research Base striving to enhance membership by committed investigators, especially by attracting additional investigators to pursue digestive disease studies. The Internal Advisory Committee will meet quarterly and will provide regular input to the Executive Committee regarding the strategic direction of the Center and will facilitate communication with institutional leaders to ensure that the Center remains responsive to overall institutional needs. The External Advisory Committee consists of four internationally prominent investigators who are leaders in digestive disease research and will meet annually in person and by conference call as needed to provide regular feedback to the Executive Committee. An Administrator will provide the necessary support for real-time financial management and operations of the Center. The administrative leadership will assure responsiveness of the Center Cores to the needs of the Research Base, and provide oversight for Core functions. In addition, the Administrative Core will support and manage the Scientific Enrichment Program, which is comprised of: i.) a seminar series involving intra- and extra-mural speakers;ii.) research retreats for the Center members and fellows/graduate students;and, iii.) a Mini-Sabbatical Program. Finally, the Administrative Core will coordinate the Pilot and Feasibility Program, which is designed to attract new and seasoned investigators to pursue digestive disease research. This Administrative Core is already functional as illustrated by the coordinated efforts required to develop and submit this proposal.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-8)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Rochester
United States
Zip Code
Yang, Liu; Kwon, Junghee; Popov, Yury et al. (2014) Vascular endothelial growth factor promotes fibrosis resolution and repair in mice. Gastroenterology 146:1339-50.e1
Guenzel, Adam J; Hillestad, Matthew L; Matern, Dietrich et al. (2014) Effects of adeno-associated virus serotype and tissue-specific expression on circulating biomarkers of propionic acidemia. Hum Gene Ther 25:837-43
Bi, Yan; Mukhopadhyay, Dhriti; Drinane, Mary et al. (2014) Endocytosis of collagen by hepatic stellate cells regulates extracellular matrix dynamics. Am J Physiol Cell Physiol 307:C622-33
White, Thomas A; LeBrasseur, Nathan K (2014) Myostatin and sarcopenia: opportunities and challenges - a mini-review. Gerontology 60:289-93
Peng, Ying; Clark, Karl J; Campbell, Jarryd M et al. (2014) Making designer mutants in model organisms. Development 141:4042-54
Yaqoob, Usman; Jagavelu, Kumaravelu; Shergill, Uday et al. (2014) FGF21 promotes endothelial cell angiogenesis through a dynamin-2 and Rab5 dependent pathway. PLoS One 9:e98130
Koh, Kwi Hye; Pan, Xian; Zhang, Wei et al. (2014) Kr├╝ppel-like factor 9 promotes hepatic cytochrome P450 2D6 expression during pregnancy in CYP2D6-humanized mice. Mol Pharmacol 86:727-35
Razumilava, Nataliya; Gradilone, Sergio A; Smoot, Rory L et al. (2014) Non-canonical Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma. J Hepatol 60:599-605
Bhat, Mamatha; Chaiteerakij, Roongruedee; Harmsen, William S et al. (2014) Metformin does not improve survival in patients with hepatocellular carcinoma. World J Gastroenterol 20:15750-5
Tabibian, James H; O'Hara, Steven P; Splinter, Patrick L et al. (2014) Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis. Hepatology 59:2263-75

Showing the most recent 10 out of 156 publications